Pentax, Takeda & more — 6 GI company key notes

Here are six updates on GI companies from the past week:

Advertisement

Pentax Medical acquired a controlling interest in PlasmaBiotics SAS, an endoscope drying and storage device manufacturer.

Takeda completed its squeeze-out of TiGenix, acquiring complete control of the company.

Takeda entered into an agreement with HiFiBiO to research antibody therapies to treat gastrointestinal diseases, cancer and other disorders.

To expand its presence in the endoscopy market, Fujifilm Medical Systems U.S.A. launched its new 700 Series Endoscopes, growing its Eluxeo platform.

The Japanese Patent Office issued Motus GI a patent for its Pure-Vu colonoscopy preparation system.

A new test from Rhythm Biosciences has the potential to detect a type of colon polyp often missed by colonoscopies.

More articles on GI and endoscopy:
What’s important to patients post-colorectal surgery? 3 study insights
This low-cost solution improved ADRs for GIs: 6 important research findings
These 25 states have CRC control programs

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.